Eragen Biosciences, Inc.

FDA Regulatory Profile

Eragen Biosciences, Inc. appears in FDA public data with 0 recalls, 2 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on August 3, 2011.

Summary

Total Recalls
0
510(k) Clearances
2
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K111527MULTICODE-RTX HERPES SIMPLEX VIRUS 1 & 2 KITAugust 3, 2011
K100336MULTICODE - RTX HERPES SIMPLEX VIRUS 1 AND 2 KIT, MODEL 3711May 12, 2010